Jivi Kit
Product Images NDC 0026-3950

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Jivi (NDC 0026-3950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jivi-antihemophilic Factor (recombinant), Pegylated-aucl (Image 01)

Jivi-antihemophilic Factor (recombinant), Pegylated-aucl (Image 01)
An instructional diagram showing components of the Jivi kit, including a vial with a protective cap, a plastic housing vial adapter with a paper cover over the thread, a pre-filled syringe labeled with parts such as syringe tip, syringe cap, barrel, and threaded rubber stopper, and a plunger rod with thread and top plate.*
FDA Label Image

Reconstitution A (Image 02)

Reconstitution A (Image 02)
An instructional illustration showing a hand holding a vial and a syringe or needle, indicating the preparation or handling of the product Jivi (Antihemophilic Factor [Recombinant] Pegylated-aucl). This image likely demonstrates proper technique for drawing or administering the medication from the vial.*
FDA Label Image

Reconstitution B (Image 03)

Reconstitution B (Image 03)
An instructional illustration showing a person holding a vial and removing the cap by pulling upward. The image demonstrates proper technique for opening the vial cap, likely part of preparing the Jivi antihemophilic factor recombinant pegylated-aucl kit.*
FDA Label Image

Reconstitution C (Image 04)

Reconstitution C (Image 04)
Illustration showing step 'c' in a sequence for preparing a medication kit. It depicts a hand holding a vial and removing a protective cap from the vial's stopper, likely part of the preparation process for the Jivi antihemophilic factor (recombinant) pegylated-aucl kit.*
FDA Label Image

Reconstitution D (Image 05)

Reconstitution D (Image 05)
An instructional illustration showing hands assembling or preparing a component of a medical kit, likely related to the reconstitution or administration of Jivi (Antihemophilic Factor, Recombinant, Pegylated-aucl). The image emphasizes the manipulation of small apparatus parts, including a vial or syringe-based device, with line art style.*
FDA Label Image

Reconstitution E (Image 06)

Reconstitution E (Image 06)
An instructional black-and-white illustration showing a hand holding a vial and inserting a needle or syringe into the vial's stopper. This likely depicts the preparation step for the Jivi antihemophilic factor recombinant pegylated-aucl kit.*
FDA Label Image

Reconstitution F (Image 07)

Reconstitution F (Image 07)
An instructional illustration showing a hand holding a syringe above a vial with an arrow indicating the direction to insert or withdraw. This diagram likely demonstrates part of the preparation or administration process for the Jivi kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl by Bayer HealthCare LLC.*
FDA Label Image

Reconstitution G (Image 08)

Reconstitution G (Image 08)
An instructional diagram showing a hand holding a vial and a syringe, with an arrow indicating a downward motion of pressing the syringe onto the vial, illustrating a step in the preparation or assembly process of the product.*
FDA Label Image

Reconstitution H (Image 09)

Reconstitution H (Image 09)
An instructional diagram showing a hand placing a funnel-shaped adapter or device onto the top of a vial or container. The illustration likely depicts part of the preparation process for a medication kit, such as assembling or connecting components before use.*
FDA Label Image

Reconstitution I (Image 10)

Reconstitution I (Image 10)
An instructional illustration showing hands performing a step in the preparation or reconstitution of the Jivi (Antihemophilic Factor Recombinant Pegylated-aucl) kit. The image depicts holding and manipulating a small vial or syringe component as part of the process.*
FDA Label Image

Reconstitution J (Image 11)

Reconstitution J (Image 11)
An instructional illustration depicting the use of a syringe. A hand is shown holding the syringe, and another hand is stabilizing it, with an arrow indicating the direction of motion involved in the process.*
FDA Label Image

Reconstitution K (Image 12)

Reconstitution K (Image 12)
An instructional illustration showing a person's hands assembling or connecting components, likely related to preparing or administering a medication. The image depicts a step involving attaching or inserting one piece into another, consistent with kit assembly instructions.*
FDA Label Image

500 Iu Carton (Image 13)

500 Iu Carton (Image 13)
Packaging label for Jivi 500 IU Range kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl, Recombinant Factor VIII. The label shows it includes a needleless reconstitution set and vial adapter for intravenous use, distributed by Bayer HealthCare LLC. Instructions for reconstitution and administration are noted on the label.*
FDA Label Image

1000 Iu Carton (Image 14)

1000 Iu Carton (Image 14)
Packaging label for Jivi 1000 IU Range, a kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl (Recombinant Factor VIII) by Bayer HealthCare LLC. The label indicates it includes a needleless reconstitution set and vial adapter for intravenous use, with instructions to reconstitute with 2.5 mL Sterile Water for Injection and use within 3 hours after reconstitution.*
FDA Label Image

2000 Iu Carton (Image 15)

2000 Iu Carton (Image 15)
Packaging label for Jivi 2000 IU Range, a kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl (Recombinant Factor VIII) indicated for intravenous use. The label shows Bayer HealthCare LLC as the labeler and includes a visual of the needleless reconstitution set with vial adapter. Instructions mention reconstitution with 2.5 mL sterile water for injection and to administer within 3 hours after reconstitution.*
FDA Label Image

3000 Iu Carton (Image 16)

3000 Iu Carton (Image 16)
Packaging label for Jivi 3000 IU Range kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl, a recombinant Factor VIII with vial adapter for intravenous use. The label shows the Bayer HealthCare LLC logo and indicates needleless reconstitution set. It includes instructions for reconstitution with 2.5 mL sterile water for injection and administration timeline after reconstitution.*
FDA Label Image

Image A (Image 17)

Image A (Image 17)
An instructional diagram showing a hand holding a vial with a cap being twisted and lifted off. This image likely demonstrates the initial step of preparing the Jivi antihemophilic factor recombinant pegylated-aucl kit for use.*
FDA Label Image

Image B (Image 18)

Image B (Image 18)
An instructional illustration showing a person using their hands to connect or cap a vial or container, indicating downward movement. The image appears to be part of usage directions for a medical product kit.*
FDA Label Image

Image C (Image 19)

Image C (Image 19)
An instructional illustration showing a hand opening a vial with a cap and removing a protective seal, demonstrating preparation steps for the Jivi kit containing Antihemophilic Factor (Recombinant) Pegylated-aucl.*
FDA Label Image

Image D (Image 20)

Image D (Image 20)
Illustration showing a close-up of hands manipulating parts of a medical device or kit component, likely related to the Jivi Antihemophilic Factor (Recombinant) Pegylated-aucl kit. The image focuses on the connection or assembly of two parts with an arrow indicating movement or direction.*
FDA Label Image

Image E (Image 21)

Image E (Image 21)
An instructional black-and-white line drawing illustrating a person pouring liquid from one container into another, likely part of mixing or preparation steps for a medication kit. The image focuses on demonstrating proper handling technique for the product.*
FDA Label Image

Image F (Image 22)

Image F (Image 22)
An instructional illustration showing a hand twisting off the cap from a vial using a twisting motion indicated by curved arrows. The image is in black and white and depicts part of a kit, potentially related to medication preparation.*
FDA Label Image

Image G (Image 23)

Image G (Image 23)
An instructional illustration showing a hand holding a vial with a plunger being pushed down as indicated by a downward arrow. This image likely demonstrates part of the preparation or mixing process for the Jivi Antihemophilic Factor (Recombinant) Pegylated-aucl kit by Bayer HealthCare LLC.*
FDA Label Image

Image H (Image 24)

Image H (Image 24)
An illustration showing a hand holding and placing a cap on a small vial, likely part of a medication preparation or administration process. The image is a black and white line drawing without text, focusing on the vial and hand interaction.*
FDA Label Image

Image I (Image 25)

Image I (Image 25)
An instructional illustration showing hands preparing an injection with a syringe. One hand holds the syringe while the other is pulling a cap or stopper off a vial or needle with an upward arrow indicating the removal direction. The image is labeled with the number 1 in the top corner.*
FDA Label Image

Image J (Image 26)

Image J (Image 26)
An instructional illustration showing the assembly of a syringe and vial or vial cap, depicting a hand holding the syringe and another hand holding the vial or vial cap, with an arrow indicating the direction to attach or remove the parts. This is part of a kit for the product Jivi, an Antihemophilic Factor (Recombinant) Pegylated-aucl.*
FDA Label Image

Image K (Image 27)

Image K (Image 27)
An instructional illustration showing hands assembling a kit component by twisting a small part onto a larger base, indicating connection or preparation steps for use. The image is labeled with the letter 'K' in the top corner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.